NasdaqGS - Nasdaq Real Time Price USD

Intuitive Surgical, Inc. (ISRG)

424.83 -13.17 (-3.01%)
As of 10:57:14 am GMT-4. Market open.
ISRG Q3 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for ISRG
  • Previous close 438.00
  • Open 402.49
  • Bid 425.09 x 100
  • Ask 408.00 x 100
  • Day's range 398.99 - 432.49
  • 52-week range 328.57 - 603.88
  • Volume 1,918,302
  • Avg. Volume 2,549,356
  • Market cap (intra-day) 150.083B
  • Beta (5Y monthly) --
  • PE ratio (TTM) 48.72
  • EPS (TTM) 8.72
  • Earnings date 20 Oct 2026
  • Forward dividend & yield -- (0.00%)
  • Ex-dividend date --
  • 1y target est 478.87

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

www.intuitive.com

17,021

Full-time employees

31 December

Fiscal year ends

Healthcare

Sector

Medical Instruments & Supplies

Industry

Performance overview

Trailing total returns as of 21/10/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD return

ISRG
24.99%
S&P 500 (^GSPC)
13.00%

1-year return

ISRG
8.19%
S&P 500 (^GSPC)
14.85%

3-year return

ISRG
59.17%
S&P 500 (^GSPC)
83.13%

5-year return

ISRG
25.09%
S&P 500 (^GSPC)
70.02%

Earnings trends

View more

Earnings per share

GAAP
Normalised
GAAP
Normalised
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 3.05B
Earnings 522.8M
Profit margin 17.15%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
1B
2B
3B
18.0%
20.0%
22.0%
24.0%
26.0%
28.0%
 

Analyst insights

View more

Analysts' price targets

324.00 Low
478.87 Average
424.83 Current
685.00 High
 

Analyst recommendations

  • Strong buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest rating

Date 21/10/2026
Analyst Evercore ISI Group
Rating action Maintains
Rating In-Line
Price action Lowers
Price target 400 -> 385
 

Statistics

View more

Valuation measures

As of 22/09/2026
  • Market cap

    142.05B

  • Enterprise value

    136.83B

  • Trailing P/E

    46.11

  • Forward P/E

    33.33

  • PEG ratio (5-yr expected)

    1.87

  • Price/sales (ttm)

    13.11

  • Price/book (mrq)

    7.82

  • Enterprise value/revenue

    12.40

  • Enterprise value/EBITDA

    32.23

Financial highlights

Profitability and income statement

  • Profit margin

    25.54%

  • Return on assets (ttm)

    10.61%

  • Return on equity (ttm)

    17.93%

  • Revenue (ttm)

    11.58B

  • Net income avi to common (ttm)

    2.96B

  • Diluted EPS (ttm)

    8.72

Balance sheet and cash flow

  • Total cash (mrq)

    6.8B

  • Total debt/equity (mrq)

    --

  • Levered free cash flow (ttm)

    --

Compare

Select to analyse similar companies using key performance metrics; select up to four stocks.

People also watch